Suppr超能文献

佛罗里达州医用大麻对患者潜在治疗效益的混合方法研究。

Mixed methods study of the potential therapeutic benefits from medical cannabis for patients in Florida.

机构信息

College of Pharmacy & Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, United States.

College of Pharmacy & Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, United States.

出版信息

Complement Ther Med. 2021 Mar;57:102669. doi: 10.1016/j.ctim.2021.102669. Epub 2021 Jan 15.

Abstract

OBJECTIVES

To evaluate medical marijuana patients' perceptions of therapeutic benefits for self-reported medical conditions.

DESIGN

The study was a concurrent mixed methods study with adult medical marijuana patients. Survey data were collected using a web-based survey, and interviews were conducted in person or over the phone.

SETTING

The study recruited 196 medical marijuana patients to complete surveys and 13 patients to participate in qualitative interviews in Florida.

MEASURES

A validated patient survey was distributed via Florida medical marijuana social media groups to examine the therapeutic benefits of the cannabis plant for medical conditions and overall well-being. Concurrently, qualitative interviews were conducted to understand barriers and facilitators to accessing medical cannabis and explore preferences for different forms and strains, as well as any unexpected side effects.

RESULTS

Patients used medical cannabis for relief of chronic pain or depression, followed by arthritis and nausea. Survey results indicated 89 % of patients reported "great relief" for their medical condition. Over 76 % of patients reported a score of 8 or higher on a 10-point scale that their medical condition had improved, and over 68 % reported a score of 8 or higher that medical cannabis had reduced their pain. Interviews indicated medical cannabis was effective for pain relief and reducing the use of prescription medicines, but the drug was perceived as too expensive.

CONCLUSIONS

Medical marijuana patients were positive about the health benefits they received and the fact they were able to reduce or eliminate many prescription medications; however, there were concerns about the costs.

摘要

目的

评估医用大麻患者对自我报告疾病的治疗益处的看法。

设计

这是一项同时进行的混合方法研究,纳入了成年医用大麻患者。通过基于网络的调查收集调查数据,并通过当面或电话进行访谈。

地点

该研究在佛罗里达州招募了 196 名医用大麻患者完成调查,并招募了 13 名患者进行定性访谈。

措施

通过佛罗里达州医用大麻社交媒体群组分发了经过验证的患者调查问卷,以评估大麻植物对医疗状况和整体健康的治疗益处。同时,进行了定性访谈,以了解获得医用大麻的障碍和促进因素,探讨对不同形式和品种的偏好,以及任何意外的副作用。

结果

患者使用医用大麻缓解慢性疼痛或抑郁,其次是关节炎和恶心。调查结果表明,89%的患者报告称他们的疾病状况“有很大缓解”。超过 76%的患者报告称,他们的疾病状况在 10 分制中得到了 8 分或更高的改善评分,超过 68%的患者报告称医用大麻降低了他们的疼痛评分达到 8 分或更高。访谈表明医用大麻对缓解疼痛和减少处方药使用有效,但患者认为该药物太贵。

结论

医用大麻患者对他们所获得的健康益处以及能够减少或消除许多处方药的事实持积极态度;然而,他们对成本表示担忧。

相似文献

1
Mixed methods study of the potential therapeutic benefits from medical cannabis for patients in Florida.
Complement Ther Med. 2021 Mar;57:102669. doi: 10.1016/j.ctim.2021.102669. Epub 2021 Jan 15.
3
Medical Cannabis Use in Glioma Patients Treated at a Comprehensive Cancer Center in Florida.
J Palliat Med. 2019 Oct;22(10):1202-1207. doi: 10.1089/jpm.2018.0528. Epub 2019 May 13.
4
Calling for Openness to the Study of Cannabis Use in Chronic Pelvic Pain.
J Obstet Gynaecol Can. 2021 May;43(5):611-613. doi: 10.1016/j.jogc.2020.08.021. Epub 2020 Sep 30.
6
Therapeutic benefits of cannabis: a patient survey.
Hawaii J Med Public Health. 2014 Apr;73(4):109-11.
9
Use of Cannabis to Relieve Pain and Promote Sleep by Customers at an Adult Use Dispensary.
J Psychoactive Drugs. 2019 Nov-Dec;51(5):400-404. doi: 10.1080/02791072.2019.1626953. Epub 2019 Jul 2.
10
Perception of Benefits and Harms of Medical Cannabis among Seriously Ill Patients in an Outpatient Palliative Care Practice.
J Palliat Med. 2020 Apr;23(4):558-562. doi: 10.1089/jpm.2019.0211. Epub 2019 Sep 20.

引用本文的文献

2
Views and practices on medical cannabis of unlicensed providers in Thailand: a qualitative study.
F1000Res. 2024 Aug 27;11:365. doi: 10.12688/f1000research.110367.3. eCollection 2022.
3
Discussions on Medical Cannabis: Addressing Missed Opportunities in Cancer Education.
J Cancer Educ. 2024 Jun;39(3):217-219. doi: 10.1007/s13187-024-02402-3.
5
The impact of education on attitudes toward medical cannabis.
PEC Innov. 2021 Dec 3;1:100009. doi: 10.1016/j.pecinn.2021.100009. eCollection 2022 Dec.
6
Demographic factors that impact attitudes toward medical cannabis.
PEC Innov. 2022 Sep 14;1:100085. doi: 10.1016/j.pecinn.2022.100085. eCollection 2022 Dec.
7
How Demographic Factors Impact Attitudes Toward the Recreational Use of Cannabis.
Cureus. 2023 Jan 28;15(1):e34304. doi: 10.7759/cureus.34304. eCollection 2023 Jan.
8
Differences in Attitudes Toward Medical Cannabis With Humanized Patient Scenarios.
Cureus. 2022 Aug 24;14(8):e28354. doi: 10.7759/cureus.28354. eCollection 2022 Aug.
10
Perceived Stigma of Patients Undergoing Treatment with Cannabis-Based Medicinal Products.
Int J Environ Res Public Health. 2022 Jun 19;19(12):7499. doi: 10.3390/ijerph19127499.

本文引用的文献

1
Medical cannabis for chronic pain: can it make a difference in pain management?
J Anesth. 2020 Feb;34(1):95-103. doi: 10.1007/s00540-019-02680-y. Epub 2019 Sep 18.
2
Evidence for the use of cannabinoids in Parkinson's disease.
J Neural Transm (Vienna). 2019 Jul;126(7):913-924. doi: 10.1007/s00702-019-02018-8. Epub 2019 May 27.
3
A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers.
BMC Fam Pract. 2019 Jan 22;20(1):17. doi: 10.1186/s12875-019-0906-y.
4
Barriers to Achieving Optimal Success with Medical Cannabis: Opportunities for Quality Improvement.
J Altern Complement Med. 2019 Jan;25(1):5-7. doi: 10.1089/acm.2018.0250. Epub 2018 Sep 6.
6
Cannabis-based medicines for chronic neuropathic pain in adults.
Cochrane Database Syst Rev. 2018 Mar 7;3(3):CD012182. doi: 10.1002/14651858.CD012182.pub2.
7
Medical Cannabis for Neuropathic Pain.
Curr Pain Headache Rep. 2018 Feb 1;22(1):8. doi: 10.1007/s11916-018-0658-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验